Zanubrutinib 80 MG ( DrugBank: Zanubrutinib )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
300IgG4関連疾患1

300. IgG4関連疾患


臨床試験数 : 40 薬物数 : 47 - (DrugBank : 21) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 141
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04602598
(ClinicalTrials.gov)
August 1, 202220/10/2020Zanubrutinib in Patients With IgG4-Related DiseaseA Phase II, Single-Site, Open-Label Study of Zanubrutinib in Patients With IgG4-Related DiseaseIgG4 Related DiseaseDrug: Zanubrutinib 80 MGMatthew C. BakerStanford UniversityRecruiting18 Years85 YearsAll10Phase 2United States